Marvin E. Rosenthale

Nessuna posizione attualmente

90 anni

Health Technology

Consumer Services

Profilo

Marvin E.
Rosenthale was the founder of Medinox, Inc. founded in 1995 where he held the title of Director until 2018.
He was the President & Chief Executive Officer of Allergan Ligand Retinoid Therapeutics, Inc. from 1993 to 1999.
He was also a Director at Radient Pharmaceuticals Corp.
in 2006, and an Independent Non-Executive Director at Windtree Therapeutics, Inc. from 1998 to 2018.
Additionally, he was a Director at Allergan Specialty Therapeutics, Inc. in 2000.
Dr. Rosenthale held the title of Executive Director-Drug Discovery Research at Hahnemann University and Ortho Pharmaceutical Corp.
He was also the Vice President-Drug Discovery Worldwide at R.W.
Johnson Pharmaceutical Research Institute.
Dr. Rosenthale received his undergraduate and graduate degrees from the University of the Sciences in Philadelphia and his doctorate from Drexel University College of Medicine.

Precedenti posizioni note di Marvin E. Rosenthale

Società	Posizione	Fine
Medinox, Inc. Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA.	Fondatore	13/08/2018
WINDTREE THERAPEUTICS, INC.	Direttore/Membro del Consiglio	13/08/2018
NURX PHARMACEUTICALS INC	Direttore/Membro del Consiglio	02/07/2010
RADIENT PHARMACEUTICALS CORP	Direttore/Membro del Consiglio	01/01/2006
Allergan Specialty Therapeutics, Inc. Allergan Specialty Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Specialty Therapeutics, Inc. is a company that develops pharmaceutical products based on retinoid and neuroprotective technologies. The company is based in Irvine, CA. Allergan Specialty Therapeutics was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 23, 2001 for $71.02 million.	Direttore/Membro del Consiglio	01/01/2000

Vedi nel dettaglio l'esperienza di Marvin E. Rosenthale

Formazione di Marvin E. Rosenthale

University of the Sciences in Philadelphia	Graduate Degree
Drexel University College of Medicine	Doctorate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Marvin E. Rosenthale

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa	1
WINDTREE THERAPEUTICS, INC.	Health Technology

Aziende private	8
Allergan Ligand Retinoid Therapeutics, Inc. Allergan Ligand Retinoid Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Allergan Ligand Retinoid Therapeutics, Inc. discovers and develops pharmaceuticals and drugs based on retinoids. Retinoids have biological actions and evidence suggests that retinoids are useful in the treatment of skin diseases, metabolic diseases, cancer including kidney cancer, certain forms of leukemia, other cancers and eye diseases. Allergan Ligand Retinoid Therapeutics was founded in 1994 and is headquartered in Irvine, CA.	Health Technology
Radient Pharmaceuticals Corp. Radient Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Radient Pharmaceuticals Corp. was engaged in the research, development, manufacturing, sale and marketing of its Onko-Sure test kit, a proprietary in-vitro diagnostic cancer test. The company was founded in 1987 and was headquartered in Tustin, CA.	Health Technology
Allergan Specialty Therapeutics, Inc. Allergan Specialty Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of AbbVie, Inc., Allergan Specialty Therapeutics, Inc. is a company that develops pharmaceutical products based on retinoid and neuroprotective technologies. The company is based in Irvine, CA. Allergan Specialty Therapeutics was acquired by Allergan, Inc., part of AbbVie, Inc. from June 15, 2015 on April 23, 2001 for $71.02 million.	Health Technology
Medinox, Inc. Medinox, Inc. Pharmaceuticals: MajorHealth Technology Medinox, Inc. manufactures pharmaceuticals. It develops new small molecule drugs to treat medical needs including sepsis, arthritis & inflammation, diabetes and sickle cell anemia. The company was founded in May 1995 by Ching-San Lai, Marvin E. Rosenthale and Ernest Chun-Ming Huang and is headquartered in Carlsbad, CA.	Health Technology
NuRx Pharmaceuticals, Inc. NuRx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NuRx Pharmaceuticals, Inc. manufactures pharmaceutical products. It engages in treatment of cancer, chemotherapy associated neutropenia, bone marrow function, bone metabolism and lipid metabolism. The company was founded on August 14, 2001 and is headquartered in Irvine, CA.	Health Technology
R.W. Johnson Pharmaceutical Research Institute
Orphagen Pharmaceuticals Orphagen Pharmaceuticals Pharmaceuticals: MajorHealth Technology Orphagen Pharmaceuticals develops and manufactures drugs. The company was founded by Scott Thacher in 2001 and is headquartered in San Diego, CA.	Health Technology
Ortho Pharmaceutical Corp.

Vedi le connessioni aziendali